PH30083A - Treatment of lower urinary tract disorders - Google Patents

Treatment of lower urinary tract disorders

Info

Publication number
PH30083A
PH30083A PH43958A PH43958A PH30083A PH 30083 A PH30083 A PH 30083A PH 43958 A PH43958 A PH 43958A PH 43958 A PH43958 A PH 43958A PH 30083 A PH30083 A PH 30083A
Authority
PH
Philippines
Prior art keywords
urinary tract
lower urinary
treatment
tract disorders
disorders
Prior art date
Application number
PH43958A
Other languages
English (en)
Inventor
Mark Mortensen Foreman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH30083A publication Critical patent/PH30083A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PH43958A 1991-02-25 1992-02-21 Treatment of lower urinary tract disorders PH30083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66076791A 1991-02-25 1991-02-25

Publications (1)

Publication Number Publication Date
PH30083A true PH30083A (en) 1996-12-27

Family

ID=24650885

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43958A PH30083A (en) 1991-02-25 1992-02-21 Treatment of lower urinary tract disorders

Country Status (12)

Country Link
US (1) US5441985A (fr)
EP (1) EP0501705B1 (fr)
JP (1) JP3222524B2 (fr)
KR (1) KR920016088A (fr)
AT (1) ATE137965T1 (fr)
AU (1) AU642582B2 (fr)
CA (1) CA2061665C (fr)
DE (1) DE69210654T2 (fr)
DK (1) DK0501705T3 (fr)
HU (1) HU215122B (fr)
PH (1) PH30083A (fr)
ZA (1) ZA921292B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US6113876A (en) * 1996-01-29 2000-09-05 Eli Lilly And Company Methods of increasing sphincter competence
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
DE60022692T2 (de) * 1999-07-01 2006-06-22 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
JP4337201B2 (ja) 1999-12-27 2009-09-30 トヨタ紡織株式会社 スプリング構造体の取付構造
JP4348808B2 (ja) 1999-12-27 2009-10-21 トヨタ紡織株式会社 枠体に対する機能性部材の取付構造
ES2305221T3 (es) * 2001-03-06 2008-11-01 Eli Lilly And Company Inhibidor de la captacion de monoamina.
EP1424079A1 (fr) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
WO2004050690A1 (fr) 2002-12-02 2004-06-17 Xenome Ltd Nouveaux peptides (-i) de $g(x)-conotoxine
EP2412719A1 (fr) 2002-12-02 2012-02-01 Xenome Ltd Pptides de chi-conotoxine
JP2006522144A (ja) * 2003-04-04 2006-09-28 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 下部尿路障害の治療方法
AU2004312059A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
JP4185154B2 (ja) * 2004-04-30 2008-11-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 中枢神経系障害治療用の置換モルホリン化合物
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
US20060189698A1 (en) * 2005-02-24 2006-08-24 Check Jerome H Treatment of interstitial cystitis
KR101220803B1 (ko) 2010-12-28 2013-01-11 주식회사 포스코 차량용 시트 구조
DE102013019618B4 (de) * 2013-11-25 2024-08-29 Avlen Georges Tri- und Tetracyclische Verbindungen zur Behandlung von Inkontinenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
PL233786A1 (fr) * 1980-11-14 1982-05-24 Lilly Co Eli
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
CA1329937C (fr) * 1987-04-09 1994-05-31 Dennis Charles Thompson 1-phenyl-3-naphtalenyloxpropanamines
SE8804003D0 (sv) * 1988-11-04 1988-11-04 Pharmacia Ab Compounds for the treatment of urinary incontinence

Also Published As

Publication number Publication date
JP3222524B2 (ja) 2001-10-29
AU1117092A (en) 1992-08-27
US5441985A (en) 1995-08-15
JPH0570343A (ja) 1993-03-23
EP0501705B1 (fr) 1996-05-15
DK0501705T3 (da) 1996-06-03
ATE137965T1 (de) 1996-06-15
DE69210654D1 (de) 1996-06-20
HUT62192A (en) 1993-04-28
HU215122B (hu) 1998-09-28
HU9200602D0 (en) 1992-05-28
EP0501705A1 (fr) 1992-09-02
ZA921292B (en) 1993-08-23
CA2061665A1 (fr) 1992-08-26
KR920016088A (ko) 1992-09-24
CA2061665C (fr) 2002-04-16
AU642582B2 (en) 1993-10-21
DE69210654T2 (de) 1996-10-24

Similar Documents

Publication Publication Date Title
PH30083A (en) Treatment of lower urinary tract disorders
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP1029540A3 (fr) Utilisation de la droloxifène pour le traitement de maladies cardiovasculaires
PL299814A1 (en) Pharmaceutical preparation inhibiting depletion of human bone tissue
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
HU9203288D0 (en) Method for producing a compound of medical effect
EP0279887A3 (en) Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
EP0448004A3 (en) Catheter for medical treatment
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
WO1986006960A3 (fr) Utilisation de nicorandile ou de pinacidile dans le traitement de maladies vasculaires peripheriques
EP0666745A4 (fr) Procedes de diagnostic et de traitement de la maladie de parkinson.
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
ZA933567B (en) Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease
EP0408525A3 (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
GR3015107T3 (en) Use of zofenopril for the preparation of drugs against rheumatoid arthritis.
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis